• Profile
Close

Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumab

Rheumatology Jul 19, 2018

Behrens F, et al. - Authors assessed the minimal disease activity (MDA) assessments in patients with PsA during routine clinical care. A stable and valid assessment of clinical status was provided by MDA over 24 months in this observational cohort of patients with long-standing disease. At month 6, MDA was achieved by about half of patients (51.5%) with an ACR20 response. Achievement of MDA at month 6 was predicted by higher functional status and fewer tender joints at baseline. The most difficult individual criterion to achieve was pain and the least difficult was enthesitis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay